Stockreport

CGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results [Yahoo! Finance]

NOVONIX Limited  (NVX) 
NASDAQ:AMEX Investor Relations: nuveen.com/cef/product/overview.aspx?fundcode=nac
PDF SEOUL, South Korea April 7, 2026 /PRNewswire/ -- CGBIO (CEO Hyunseung Yu), a biotechnology company specializing in regenerative medicine, announced on the 6th that it p [Read more]